Glaxo Decision Precedes Obamacare Rollout
Scientific American: Mind and Brain
Pharmaceutical giant GlaxoSmithKline's announcement on December 16 that it will cease paying doctors to promote its products took the medical community by surprise, but the plan appears to have been in the works for some time.
Employing doctors to promote brand-name drugs at conferences has been an industry standard for decades, and many researchers and consumer advocates claim that the practice creates an unethical conflict of interest. The Physician Payment Sunshine Act, a provision of the 2010 Affordable Care Act, requires drug manufacturers to report these payments to the federal government. In an effort to increase transparency the data will be published online starting next year.
[More]
Original Article: http://www.scientificamerican.com/blog/post.cfm?id=glaxo-decision-to-end-promotional-payments-to-physicians-precedes-obamacare-rollout
No comments:
Post a Comment